Cecilia Zhang

Cecilia Zhang

Company: Biosyngen Group

Job title: Chief Scientific Officer

Seminars:

Roundtable Discussion: Highlighting Key TIL Genetic Targets Amenable for Engineering Enhanced TILs 12:00 pm

Discussing which TIL genes may be of interest to amend for desired characteristics What makes a TIL gene a good target for modification? What are some of the most common TIL genes being modified and what makes them good targets?Read more

day: Conference Day One - Track A - AM

Cutting-Edge MSETM-TIL Platform for Enhanced Anti- Tumor Efficacy with Broader Clinical Applications 1:30 pm

Introduction of the company and the backgroundUnique features of Biosyngen’s MSETM-TIL platform Efficient ex vivo expansion from tumor biopsy samples Efficient genetic modification system Pre-clinical data on anti-tumor efficacy of the MSETM-TIL systemRead more

day: Conference Day One - Track B - PM

Preclinical & Translation
10:15 am

Read more

day: Conference Day One - Track A - AM

Preclinical & Translation
10:30 am

Read more

day: Conference Day Two - Track A - AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.